APA (7th ed.) Citation

Konstan, M. W., Flume, P. A., Kappler, M., Chiron, R., Higgins, M., Brockhaus, F., . . . Geller, D. E. (2011). Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial. Journal of cystic fibrosis, 10(1), 54-61. https://doi.org/10.1016/j.jcf.2010.10.003

Chicago Style (17th ed.) Citation

Konstan, Michael W., et al. "Safety, Efficacy and Convenience of Tobramycin Inhalation Powder in Cystic Fibrosis Patients: The EAGER Trial." Journal of Cystic Fibrosis 10, no. 1 (2011): 54-61. https://doi.org/10.1016/j.jcf.2010.10.003.

MLA (9th ed.) Citation

Konstan, Michael W., et al. "Safety, Efficacy and Convenience of Tobramycin Inhalation Powder in Cystic Fibrosis Patients: The EAGER Trial." Journal of Cystic Fibrosis, vol. 10, no. 1, 2011, pp. 54-61, https://doi.org/10.1016/j.jcf.2010.10.003.